pdufa.bio
HomeReadouts › January 2027

January 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for January 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← December 2026February 2027 →
13 readouts
ELVN · Jan 2027 (est.)
ELVN-002: HER2-positive Breast Cancer
Awaiting dataupdated 7mo ago
EXEL · Jan 2027 (est.)
Cabozantinib: Germ Cell Tumor
NUVL · Jan 2027 (est.)
Neladalkib: Locally Advanced Solid Tumor
PCVX · Jan 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
RARE · Jan 2027 (est.)
Setrusumab: Osteogenesis Imperfecta
SIGA · Jan 2027 (est.)
Tecovirimat Oral Capsule: Smallpox
Awaiting data
CADL · Jan 2027 (est.)
Aglatimagene Besadenovec: Malignant Glioma of Brain
Awaiting dataupdated 4mo ago
BMY · Jan 2027 (est.)
Nivolumab: Hodgkin Lymphoma
REGN · Jan 2027 (est.)
Odronextamab: Follicular Lymphoma
OCUL · Jan 2027 (est.)
Otx-Tki: Neovascular Age-related Macular Degeneration
Awaiting dataupdated 12mo ago
GILD · Jan 2027 (est.)
MK-3475: Carcinoma, Non-Small-Cell Lung
IDYA · Jan 2027 (est.)
Darovasertib: Metastatic Uveal Melanoma
Awaiting dataupdated 4mo ago
APLM · Jan 2027 (est.)
Uproleselan: Metastatic Non Small Cell Lung Cancer
Awaiting dataupdated 5mo ago
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).